Skip to main content

Lancet study finds no significant clinical benefits of antiviral drug remdesivir

Treatment with antiviral drug remdesivir may not significantly speed up recovery from COVID-19 in critically ill hospitalised patients compared to placebo, according to the first randomised trial of its kind published in The Lancet journal. The study led by researchers from China-Japan Friendship Hospital and Capital Medical University in China involved 237 adults aged 18 and older from ten hospitals in Wuhan.

from IndiaTV World: Google News Feed https://ift.tt/2yVKAIp

Comments

Popular posts from this blog

Singapore: Drunk Indian man jailed for assaulting police officer

A 25-year-old Indian national faces jail time after he was charged by a court in Singapore with attempting to assault a police officer and causing annoyance to the public while being drunk.  from IndiaTV World: Google News Feed http://bit.ly/2WunrCJ

Workers to protest conditions at Amazon, Instacart and other retailers Friday

Organizers say they plan a strike, or sick out, to protest the "continuing failure to provide adequate protection in the workplace."             from USATODAY - Tech Top Stories https://ift.tt/2VQTVdA

TikTok threatens legal action after President Trump issues executive order to block app

President Donald Trump issued executive orders to ban TikTok and WeChat in 45 days citing national security fears. TikTok threatens a lawsuit.             from USATODAY - Tech Top Stories https://ift.tt/2PKBMu9